vs

Side-by-side financial comparison of Regional Management Corp. (RM) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Regional Management Corp. is the larger business by last-quarter revenue ($167.3M vs $142.0M, roughly 1.2× Oncology Institute, Inc.). Regional Management Corp. runs the higher net margin — 6.8% vs -5.3%, a 12.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 9.4%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 8.2%).

Millennium Management LLC is an investment management firm with a multistrategy hedge fund offering. It is one of the world's largest alternative asset management firms with $83.4 billion assets under management as of January 2026. The firm operates in America, Europe and Asia. As of 2022, Millennium had posted the fourth highest net gains of any hedge fund since its inception in 1989.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

RM vs TOI — Head-to-Head

Bigger by revenue
RM
RM
1.2× larger
RM
$167.3M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+32.2% gap
TOI
41.6%
9.4%
RM
Higher net margin
RM
RM
12.1% more per $
RM
6.8%
-5.3%
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
8.2%
RM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
RM
RM
TOI
TOI
Revenue
$167.3M
$142.0M
Net Profit
$11.4M
$-7.5M
Gross Margin
Operating Margin
-4.9%
Net Margin
6.8%
-5.3%
Revenue YoY
9.4%
41.6%
Net Profit YoY
62.7%
43.0%
EPS (diluted)
$1.18
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RM
RM
TOI
TOI
Q1 26
$167.3M
Q4 25
$169.7M
$142.0M
Q3 25
$165.5M
$136.6M
Q2 25
$157.4M
$119.8M
Q1 25
$153.0M
$104.4M
Q4 24
$154.8M
$100.3M
Q3 24
$146.3M
$99.9M
Q2 24
$143.0M
$98.6M
Net Profit
RM
RM
TOI
TOI
Q1 26
$11.4M
Q4 25
$12.9M
$-7.5M
Q3 25
$14.4M
$-16.5M
Q2 25
$10.1M
$-17.0M
Q1 25
$7.0M
$-19.6M
Q4 24
$9.9M
$-13.2M
Q3 24
$7.7M
$-16.1M
Q2 24
$8.4M
$-15.5M
Operating Margin
RM
RM
TOI
TOI
Q1 26
Q4 25
9.5%
-4.9%
Q3 25
11.5%
-5.9%
Q2 25
8.6%
-9.4%
Q1 25
6.0%
-9.5%
Q4 24
8.2%
-11.9%
Q3 24
6.9%
-13.9%
Q2 24
7.8%
-16.6%
Net Margin
RM
RM
TOI
TOI
Q1 26
6.8%
Q4 25
7.6%
-5.3%
Q3 25
8.7%
-12.1%
Q2 25
6.4%
-14.2%
Q1 25
4.6%
-18.8%
Q4 24
6.4%
-13.1%
Q3 24
5.2%
-16.1%
Q2 24
5.9%
-15.7%
EPS (diluted)
RM
RM
TOI
TOI
Q1 26
$1.18
Q4 25
$1.30
$-0.04
Q3 25
$1.42
$-0.14
Q2 25
$1.03
$-0.15
Q1 25
$0.70
$-0.21
Q4 24
$0.96
$-0.14
Q3 24
$0.76
$-0.18
Q2 24
$0.86
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RM
RM
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$375.8M
$-15.7M
Total Assets
$2.1B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RM
RM
TOI
TOI
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$9.9M
Total Debt
RM
RM
TOI
TOI
Q1 26
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.4B
Q2 24
$1.4B
Stockholders' Equity
RM
RM
TOI
TOI
Q1 26
$375.8M
Q4 25
$373.1M
$-15.7M
Q3 25
$371.9M
$-12.3M
Q2 25
$363.0M
$-9.0M
Q1 25
$357.9M
$5.1M
Q4 24
$357.1M
$3.6M
Q3 24
$352.9M
$15.5M
Q2 24
$344.9M
$29.2M
Total Assets
RM
RM
TOI
TOI
Q1 26
$2.1B
Q4 25
$2.1B
$164.7M
Q3 25
$2.0B
$163.6M
Q2 25
$2.0B
$159.8M
Q1 25
$1.9B
$164.0M
Q4 24
$1.9B
$172.7M
Q3 24
$1.8B
$179.2M
Q2 24
$1.8B
$179.6M
Debt / Equity
RM
RM
TOI
TOI
Q1 26
Q4 25
4.40×
Q3 25
4.23×
Q2 25
4.14×
Q1 25
4.11×
Q4 24
4.12×
Q3 24
3.94×
Q2 24
3.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RM
RM
TOI
TOI
Operating Cash FlowLast quarter
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RM
RM
TOI
TOI
Q1 26
Q4 25
$309.1M
$3.2M
Q3 25
$86.7M
$-12.6M
Q2 25
$78.7M
$-10.2M
Q1 25
$63.7M
$-5.0M
Q4 24
$268.9M
$4.2M
Q3 24
$75.1M
$819.0K
Q2 24
$71.5M
$-15.7M
Free Cash Flow
RM
RM
TOI
TOI
Q1 26
Q4 25
$304.3M
$2.2M
Q3 25
$85.7M
$-13.2M
Q2 25
$77.6M
$-11.4M
Q1 25
$62.4M
$-5.3M
Q4 24
$263.9M
$2.4M
Q3 24
$73.8M
$417.0K
Q2 24
$70.3M
$-17.5M
FCF Margin
RM
RM
TOI
TOI
Q1 26
Q4 25
179.3%
1.5%
Q3 25
51.8%
-9.7%
Q2 25
49.3%
-9.5%
Q1 25
40.8%
-5.1%
Q4 24
170.4%
2.4%
Q3 24
50.4%
0.4%
Q2 24
49.1%
-17.7%
Capex Intensity
RM
RM
TOI
TOI
Q1 26
Q4 25
2.8%
0.7%
Q3 25
0.6%
0.4%
Q2 25
0.6%
1.0%
Q1 25
0.8%
0.3%
Q4 24
3.3%
1.8%
Q3 24
0.9%
0.4%
Q2 24
0.8%
1.9%
Cash Conversion
RM
RM
TOI
TOI
Q1 26
Q4 25
23.94×
Q3 25
6.04×
Q2 25
7.76×
Q1 25
9.09×
Q4 24
27.13×
Q3 24
9.80×
Q2 24
8.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RM
RM

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons